Thomas Jennings

Thomas Jennings is a Managing Director with Summit Partners, focusing primarily on the technology and healthcare & life sciences sectors. Based in Summit’s Boston office, Tom joined the firm in 1997 and today co-heads the firm’s venture capital activities in North America, Europe and Asia. He is currently a director of Accedian Networks, ApoCell, AvePoint, PeerApp, Telerik and Zenoss and is actively involved with the firm’s investments in Casa Systems, Hiperos, IMMCO Diagnostics, LogiXML, NameMedia and OB Hospitalist Group. Tom’s prior investments and directorships include Anesthetix Holdings (acquired by TeamHealth), Burst Media Corporation (AIM: BRST, later acquired by blinkx PLC), Commnet Wireless (acquired by Atlantic Tele-Network, Inc.), Fermentas International (acquired by Thermo Fisher Scientific), Hatcher Associates (acquired by Corillian Corporation), NetWitness Corporation (acquired by EMC Corporation), Sage Telecom and Unica Corporation (NASDAQ: UNCA, later acquired by IBM). Prior to Summit, he worked as a consultant with Andersen Consulting (now Accenture).

Tom holds an AB in economics and theology from Boston College, where he received the Scholar of the College award. Tom is a Trustee of the Massachusetts Soldiers Legacy Fund, an organization that provides tuition funding for the children of fallen service members from Massachusetts.